- Lobbying
- John AND Slotman
Lobbying Arrangements Results for 'John Slotman'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Efforts to treat and prevent emerging infectious diseases. |
Schiltz Foods, Inc.
|
DLA Piper LLP (US) | |||
Details Issues related to Medicare/Medicaid reimbursements. Advocacy surrounding proposed corporate merger. |
Medco Health Solutions, Inc.
|
DLA Piper LLP (US) | |||
Details Implementation of Public Law No. 111-148, provisions related to the Physician Payments Sunshine Act. Implementation of the Food Safety Modernization Act. |
iCiX International, Ltd.
|
DLA Piper LLP (US) | |||
Details Implementation of the American Taxpayer Relief Act of 2012 (P.L. No. 112-240), creation of Commission on Long-Term Care. |
Avalon Health Management
|
DLA Piper LLP (US) | |||
Details Implementation of Public Law No. 111-148. |
Fresenius Medical Care
|
DLA Piper LLP (US) | |||
Details Health care financing. |
Coalition on Health Care
|
DLA Piper LLP (US) | |||
Details Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; prescription drug abuse. Issues related to Medicare/Medicaid reimbursements. |
Pfizer, Inc.
|
DLA Piper LLP (US) | |||
Details Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program. |
Blue Cross and Blue Shield Association
|
DLA Piper LLP (US) | |||
Details Implementation of Public Law No. 111-148, provisions related to health IT. |
Aetna, Inc.
|
DLA Piper LLP (US) | |||
Details Issues related to Medicare and Medicaid reimbursements. |
National Association for Home Care and Hospice
|
DLA Piper LLP (US) | |||
Details H.R. 1851/S. 881, Family Act of 2013. S. 959, Pharmaceutical Quality, Security and Accountability Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3204, the Drug Quality an... |
EMD Serono, Inc.
|
DLA Piper LLP (US) | |||
Details Early childhood education. Child Care and Development Block Grants and Preschool Development Grants. H.R. 3358, Health and Human Services Appropriations, FY2019, provisions on early education fundi... |
The Ounce of Prevention
|
DLA Piper LLP (US) | |||
Details Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S... |
Novo Nordisk Inc.
|
DLA Piper LLP (US) | |||
Details Prescription Drug Costs. H.R.5429/S.2780: Medication Affordability and Patent Integrity Act. 180-Day Exclusivity. S.1114: Expanding Access to Low-Cost Generics Act of 2023. H.R.5461/S.2129: Ensurin... |
Association for Accessible Medicines
|
in-house lobbying | |||
Details Hill outreach to oppose site-neutral payment cuts; Hill outreach in support of the Acute Hospital Care at Home program; Hill outreach about streamlining prior authorization in Medicare Advantage pl... |
American Hospital Association
|
in-house lobbying |